Three-member expert panel will oversee process to dispose of the Sinovac-CoronaVac doses that expired in December 2023.
Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal co ...
Inquirer Opinion on MSN12h
COVID-19 in the time of DuterteFive years ago in mid-March 2020, the Philippines, like most countries, went on a lockdown never before experienced by ...
Atualmente, os imunizantes disponíveis no Brasil são a Spyevax, da Moderna, que protege contra cepas ômicron do vírus ...
4d
Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s Cell Pouch Bio-hybrid Organ as a functional cure for type 1 ...
Neste 12 de março, há exatos cinco anos da primeira morte por Covid-19 no Brasil, ocorre o lançamento do Acervo da Pandemia, ...
It's been two years since Pharmaniaga Bhd slipped into Practice Note 17 (PN17) status. Will the company's regularisation plan ...
Disagreements between high- and lower-income countries have left the pandemic preparedness treaty in intensive care. The prescription? Developing nations can look to each other for health equity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback